Ambulatory blood pressure nomogram derivation for Indian children: A pioneer study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2022 - 2027
Project Lead
Dr Priya Pais
Authors
Dr Priya Pais, Dr B Ramakrishna Goud, Dr. Girish
Project Status
ongoing
Project Type
Indian Council of Medical Research (ICMR)